A Dynamic Prognostic and Adaptive Treatment Framework for Advanced Biliary Tract Cancer

JHEP Reports · Published 2026-08-01 · DOI 10.1016/j.jhepr.2026.101976

Free full text

Authors (23)

Jun-Hao Mei, Xue Han, Kai Zhang, Nai-Jian Ge, Zhen Li, Xiu-Ping Zhang, Ping-Ping Wu, Wei-Fu Lv, Jun Wu, Jian-Xiong Wu, Chao Wang, Jie Li, Peng-Jiong Liu, Hui Yan, Zhuo Li, Jie Liu, Ying Zhang, Yue Liu, Tian Huang, Jin-He Guo, Rong Liu, Gao-Jun Teng, Jian Lu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Mei, J., Han, X., Zhang, K., et al. (2026). A Dynamic Prognostic and Adaptive Treatment Framework for Advanced Biliary Tract Cancer. JHEP Reports. https://doi.org/10.1016/j.jhepr.2026.101976

Related articles

• Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score · Cancer Immunology, Immunotherapy · 2023 · Cites or is cited by this article
• Second-line practices in the era of immunotherapy in HCC: The CHIEF cohort · JHEP Reports · 2026 · Same journal
• Interleukin-8–driven monocyte activation in primary sclerosing cholangitis: Insights from single-cell analysis and humanized immune system mice · JHEP Reports · 2026 · Same journal
• A hepatocyte-derived GPNMB–RYK signaling axis in MASH progression · JHEP Reports · 2026 · Same journal
• Development and psychometric evaluation of the Liver Disease Stigma Scale (LDSS) · JHEP Reports · 2026 · Same journal
• Global Trends in National Alcohol Control Policies Between 2010–2019 · JHEP Reports · 2026 · Same journal
• Is it too early to dismiss corticosteroids in CDK4/6 inhibitor-induced liver injury? · JHEP Reports · 2026 · Same journal
• Peripartum ALT Flares Predict Earlier Postpartum HBeAg Clearance in Highly Viremic HBV-Infected Women: A Long-term Follow-up Study · JHEP Reports · 2026 · Same journal
• The Use of FGF21 Analogues in MASH and MASH Cirrhosis – Metabolic Master Regulators or Liver-Specific Mechanisms? ☆ · JHEP Reports · 2026 · Same journal
• Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B · JHEP Reports · 2026 · Same journal